NCT01629186

Brief Summary

The nasopharyngeal oxygen (NPO) with Nose-close (NC) and Abdomen-compression (AC) technique may use for support or rescue asphyxiated infants during Flexible bronchoscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2011

Completed
10 months until next milestone

First Posted

Study publicly available on registry

June 27, 2012

Completed
Last Updated

June 27, 2012

Status Verified

June 1, 2012

Enrollment Period

1.9 years

First QC Date

September 12, 2011

Last Update Submit

June 24, 2012

Conditions

Keywords

CPRflexible bronchoscoperesuscitationventilation

Outcome Measures

Primary Outcomes (1)

  • Heart rate (beat/min)

    During and after this FB procedure, vital signs are continually monitoring. When the heart rate (HR) \<80 beat/min (measured by continuouse wave and digit form of EKG monitor) and lasting \>10 seconds. Immediately rescued with rhythmic NC-AC. If the heart rate did not reach to its acceptable level (\>80 beat/min) within 2 minutes, then traditional CPR procedures involving bag-mask ventilation, ET intubation, Ambu bag ventilation or even chest compressions were substituted.

    Participants will continually monitoring by EKG for 2 days after the procedure.

Secondary Outcomes (2)

  • Oxygen saturation by pulse oximetry

    Participants will continually monitoring by pulse oximeter for 2 days after the procedure.

  • Mean blood pressure (mmHg)

    Participants will continually monitoring by sphygmomanometer for 2 days after the procedure.

Study Arms (1)

outcome

EXPERIMENTAL

Cardiopulmonary parameters were measured and recorded at baseline, just before and at every minute during NC-AC, and at the end of the FB session. In infants who already had an arterial line, arterial blood gas (ABG) analyses were taken for study. Data was represented as mean ± SD. The results obtained from the baseline and different stages. The values were considered statistically significant only when p \< 0.05. Technique failure was defined as: any vital signs of hypoxia did not return to accepted levels(HR\>100 beat/min, SpO2\>90%, mean BP\>50 mmHg)within 2 minutes of the experimental CPR technique. Then traditional CPR procedures involving bag-mask ventilation, endotracheal intubation, Ambu bag ventilation or even chest compressions were substituted.

Other: NPO with Nose-close and Abdomen-compression

Interventions

Infants with body weight (BW) \<5.0 kg and receiving nasal diagnostic or interventional FB were enrolled. Under NPO (0.5 L/kg/min), when infant's heart rate (HR) \<80 beats/min or oxygen saturation (SpO2) \<85% for more than 10 seconds, rescue NC-AC was initiated. It was performed by (1) increased NPO flow to 0.5-1.0 L/kg/min; (2) NC 1 second for inspiration; and (3) AC 1 second for expiration with simultaneously released nostrils. Repeat doing steps (2) and (3) at a rate of 30 cycles/min until HR, SpO2, and blood pressure (BP) returned to normal.

Also known as: (1)Nasopharygeal oxygen, (2)Nose-close and Abdomen-compression
outcome

Eligibility Criteria

AgeUp to 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • body weight (BW) less than 5.0 kg;
  • receiving nasal approach flexible bronchoscopy.

You may not qualify if:

  • cannot nasal approach flexible bronchoscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei-Veterans General Hospital

Taipei, 11217, Taiwan

Location

Related Publications (1)

  • Soong WJ, Shiao AS, Jeng MJ, Lee YS, Tsao PC, Yang CF, Soong YH. Comparison between rigid and flexible laser supraglottoplasty in the treatment of severe laryngomalacia in infants. Int J Pediatr Otorhinolaryngol. 2011 Jun;75(6):824-9. doi: 10.1016/j.ijporl.2011.03.016. Epub 2011 Apr 21.

MeSH Terms

Conditions

BradycardiaHypoxiaRespiratory Aspiration

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Wen-Jue Soong, MD

    Department of Pediatrics; Taipei-Veteran General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Taipei Veterans General Hospital,Taiwan, Taipei Veterans General Hospital,Taiwan

Study Record Dates

First Submitted

September 12, 2011

First Posted

June 27, 2012

Study Start

January 1, 2007

Primary Completion

December 1, 2008

Study Completion

December 1, 2010

Last Updated

June 27, 2012

Record last verified: 2012-06

Locations